Skip to main content
Caplight Logo









Macomics

Macomics

Private
EdinburghHealthcare & Life Scienceshttps://macomics.com/

Last Round

Seed

Jul 29, 2021

Total Funding Raised

$9.97M

Company Overview

Macomics is a biotechnology company developing precision medicines designed to modulate macrophages for the treatment of cancer.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

drug discoveryimmuno-oncologymacrophage biologybiotechprecision medicineantibody therapeuticstarget identificationiPSCCRISPRdrug discovery platformtherapeutic pipelinefibrotic diseaseinflammatory disordersbiotech R&Ddrug discovery partner

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Macomics Comparables

Compare Macomics with similar companies based on industry and business-model similarity.

Macomics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Verseau Therapeutics
78%
United Immunity, Co., Ltd.
78%
LTZ Therapeutics
76%

Macomics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJul 29, 2021
SeedJul 14, 2020

Macomics Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 18, 2025

    Monthly visitors increased 347% MoM.

  • Jul 29, 2021

    $6M raised in Seed round.

Macomics Filings

Explore SEC and related filing metadata, where available.

Macomics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Macomics's valuation, stock price, and market status.

Is Macomics a public or private company?

Macomics is a private company.

What is the current stock price of Macomics?

Macomics is a private company with no public stock price. No recent secondary market data is available.

How much is Macomics worth (valuation)?

Valuation information for Macomics is not publicly available.

Can I buy Macomics stock?

Macomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Macomics's last funding round?

Macomics's most recent funding round was Seed on July 29, 2021.

Who are the main investors in Macomics?

Key investors in Macomics include Epidarex Capital.

Will Macomics IPO soon?

No public IPO plans have been announced for Macomics.

How can I track Macomics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Macomics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersEdinburgh
Employee Range18
Year Founded2018
Last FundingJul 29, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?